Literature DB >> 10428411

Decreased sensitivity to Group III mGluR agonists in the lateral perforant path following kindling.

G J Klapstein1, B S Meldrum, I Mody.   

Abstract

The ability of the selective Group III mGluR agonist L-serine-O-phosphate (L-SOP) to inhibit lateral perforant path (LPP) evoked responses in the dentate gyrus was tested in hippocampal slices from commissurally-kindled rats 1-2 days after the last seizure, implanted controls, and fully-kindled rats rested for 28 days without stimulated seizures (28 days post-seizure, 28 dps). L-SOP was more potent in controls than kindled or 28 dps animals, decreasing the fEPSP slope with IC50s of 2.4 microM, 18.7 microM and 10.5 microM, respectively. Paired pulse facilitation (PPF, 50 ms) was comparable in control and kindled rats, but was markedly reduced in 28 dps rats, indicating increased release probability. Inhibition of the field excitatory postsynaptic potentials (fEPSP) by L-SOP was correlated with enhanced PPF in all groups, affirming a presynaptic site of action. At moderate levels of L-SOP-induced inhibition (20-60%), PPF showed significantly greater enhancement in 28 dps than in the other two groups. These results are interpreted as showing a functional reduction of the presynaptic inhibitory Group III mGluR (probably mGluR8) response in the LPP after kindling. Furthermore, PPF changes indicate that the kindled state may be associated with a long-lasting increase in the probability of release from LPP terminals, which may be temporarily masked or counterbalanced by recent seizures.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10428411     DOI: 10.1016/s0028-3908(99)00016-7

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  6 in total

1.  Reduced excitatory drive onto interneurons in the dentate gyrus after status epilepticus.

Authors:  J Doherty; R Dingledine
Journal:  J Neurosci       Date:  2001-03-15       Impact factor: 6.167

Review 2.  Molecular targets for antiepileptic drug development.

Authors:  Brian S Meldrum; Michael A Rogawski
Journal:  Neurotherapeutics       Date:  2007-01       Impact factor: 7.620

3.  Increased seizure susceptibility in mice lacking metabotropic glutamate receptor 7.

Authors:  G Sansig; T J Bushell; V R Clarke; A Rozov; N Burnashev; C Portet; F Gasparini; M Schmutz; K Klebs; R Shigemoto; P J Flor; R Kuhn; T Knoepfel; M Schroeder; D R Hampson; V J Collett; C Zhang; R M Duvoisin; G L Collingridge; H van Der Putten
Journal:  J Neurosci       Date:  2001-11-15       Impact factor: 6.167

4.  Disrupted hippocampal network physiology following PTEN deletion from newborn dentate granule cells.

Authors:  Candi L LaSarge; Raymund Y K Pun; Michael B Muntifering; Steve C Danzer
Journal:  Neurobiol Dis       Date:  2016-09-03       Impact factor: 5.996

5.  The metabotropic glutamate receptor 4 is internalized and desensitized upon protein kinase C activation.

Authors:  Jesper Mosolff Mathiesen; M Teresa Ramirez
Journal:  Br J Pharmacol       Date:  2006-06       Impact factor: 8.739

6.  Agonists and antagonists of metabotropic glutamate receptors: anticonvulsants and antiepileptogenic agents?

Authors:  Feng Ru Tang
Journal:  Curr Neuropharmacol       Date:  2005-10       Impact factor: 7.363

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.